A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MDIs / metered-dose inhalers

[Related PubMed/MEDLINE]
Total Number of Papers: 248
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MDIs  (>> Co-occurring Abbreviation)
Long Form:   metered-dose inhalers
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Analysis of improved oral drug delivery with different helical stream inhalation modes. ---
2021 A simple and rapid method to simultaneously analyze ciclesonide and its impurities in a ciclesonide metered-dose inhaler using on-line supercritical fluid extraction/supercritical fluid chromatography/quadrupole time-of-flight mass spectrometry. CIC-MDI
2021 Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the Evidence. FPF
2021 Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review. COPD, ICSs, LABAs, LAMAs
2021 Parental Perception About Metered-Dose Inhalers and Nebulizers Differences Among Saudi Arabia. ---
2021 Systematic Evaluation of the Effect of Formulation Variables on In Vitro Performance of Mometasone Furoate Suspension-Metered Dose Inhalers. DD, DoE, MDT, MF
2021 The environmental impact of inhalers for asthma: A green challenge and a golden opportunity. DPIs, MART
2020 Brief Education Improves Proper Metered-Dose Inhaler Use. ED
2020 Comparison between traditional and nontraditional add-on devices used with pressurised metered-dose inhalers. TED
10  2020 Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment. CF, COPD, DPIs, SMIs
11  2020 Influence of Composition and Spray-Drying Process Parameters on Carrier-Free DPI Properties and Behaviors in the Lung: A review. DPIs
12  2020 Inhaler Technique and Self-reported Adherence to Medications Among Hospitalised People with Asthma and COPD. COPD, DPIs, MARS
13  2020 Patient Inspiratory Maneuver Performance; Peak Lungpower, Acceleration and Volume. COPD, DPIs, EH-combi, EH-mono, TH
14  2020 Primary non-adherence to inhaled medications measured with e-prescription data from Poland. DPIs
15  2020 Respiratory Tract: Structure and Attractions for Drug Delivery Using Dry Powder Inhalers. DPIs, SMIs
16  2020 Retrospective evaluation of albuterol inhalant exposure in dogs: 36 cases (2007-2017). ---
17  2020 The use of nebulized pharmacotherapies during the COVID-19 pandemic. COVID-19, SARS-CoV-2
18  2019 Carbon footprint impact of the choice of inhalers for asthma and COPD. DPIs, HFCs
19  2019 Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England. DPIs, GWP, ICS, LABA
20  2019 Development of nanodispersion-based sildenafil metered-dose inhalers stabilized by poloxamer 188: a potential candidate for the treatment of pulmonary arterial hypertension. MMAD
21  2019 ELLIPTA Dry Powder Versus Metered-Dose Inhalers in an Optimized Clinical Trial Setting. ---
22  2019 Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of U.S. Studies. CIs
23  2019 The Respimat Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients. DPIs, SMI
24  2018 A Report of an Asthma Pathway Leading to Improved Resource Use. LOS, RVP
25  2018 Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers. AS, BDP, DoE
26  2018 Measuring The Bipolar Charge Distributions of Fine Particle Aerosol Clouds of Commercial PMDI Suspensions Using a Bipolar Next Generation Impactor (bp-NGI). bp-NGI, bp-NGI, FP, ISM, NGI, SX
27  2018 Pharmacists' training to improve inhaler technique of patients with COPD in Vietnam. DPIs
28  2017 A Tablet-Based Multimedia Education Tool Improves Provider and Subject Knowledge of Inhaler Use Techniques. DPIs
29  2017 Achieving good adherence to inhaled corticosteroids after weighing canisters of asthmatic children. ---
30  2017 Effect of Spacers on the Bipolar Electrostatic Charge Properties of Metered Dose Inhaler Aerosols-A Case Study With Tilade. BOLAR
31  2017 Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler. COPD
32  2017 Influence of Formulation Factors on the Aerosol Performance of Suspension and Solution Metered Dose Inhalers: A Systematic Approach. CQAs, DD, DoE, FPD, QbD
33  2017 Instant velocity and consistency of emitted cloud change by the different levels of canister filling with Metered Dose Inhalers (MDIs), but not with Soft Mist Inhalers (SMIs): abench study. SMIs
34  2017 Patterns of use of dry powder inhalers versus pressurized metered-dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma: An observational comparative study. COPD, DPIs
35  2017 Pharmacokinetics of Beclomethasone Dipropionate Delivered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Subjects. 17-BMP, AUC, BAIs
36  2016 A Comparison of the Performance of Efficient Data Analysis Versus Fine Particle Dose as Metrics for the Quality Control of Aerodynamic Particle Size Distributions of Orally Inhaled Pharmaceuticals. APSD, DPIs, EDA, FPD, ISM, LPM/SPM, OIPs, QC
37  2016 Exploring the impact of sample flowrate on in vitro measurements of metered dose inhaler performance. ACI, APSD, USP IP
38  2016 Factors affecting the efficiency of aerosolized salbutamol delivery via a metered dose inhaler and equine spacer device. ---
39  2016 Financial effect of converting ipratropium-albuterol therapy from inhalers to nebulizer treatments at an academic health system. RT
40  2016 Inhaler Technique in Children With Asthma: A Systematic Review. ---
41  2016 Spacers versus nebulizers in treatment of acute asthma - a prospective randomized study in preschool children. PED
42  2016 Systemic Exposures of Fluticasone Propionate and Salmeterol Following Inhalation via Metered Dose Inhaler with the Mini Spacer Compared with the Aerochamber Plus Spacer. FP, SFC
43  2016 Use of simulated patient approach to assess the community pharmacists' knowledge of appropriate use of metered dose inhaler. ---
44  2015 A Comparison of Pharmaceutical Product Performance of Albuterol Inhalers Available in the United States and Those Obtained in a Mexican Border Town. ---
45  2015 A Rationale for Going Back to the Future: Use of Disposable Spacers for Pressurised Metered Dose Inhalers. VHC
46  2015 Applicability of Bipolar Charge Analyzer (BOLAR) in Characterizing the Bipolar Electrostatic Charge Profile of Commercial Metered Dose Inhalers (MDIs). BOLAR
47  2015 Validation of scores of use of inhalation devices: valoration of errors. DPIs
48  2014 A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers. MMAD
49  2014 Advances in metered dose inhaler technology: formulation development. ---
50  2014 Assessment of inhaler techniques employed by patients with respiratory diseases in southern Brazil: a population-based study. DPIs
51  2014 Establishing a quality control program: ensuring safety from contamination for recycled metered-dose inhalers. ---
52  2014 Inhaler technique training and health-care professionals: effective long-term solution for a current problem. ---
53  2014 Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease. COPD, FEV1, GP, HFA, TIO
54  2014 Treatment of chronic obstructive pulmonary disease in hospitalized geriatric patients. COPD
55  2014 Using videos to teach children inhaler technique: a pilot randomized controlled trial. ---
56  2013 A study investigating the community pharmacist knowledge about the appropriate use of inhaler, Eastern Region AlAhsa, Saudi Arabia. ---
57  2013 Advances in metered dose inhaler technology: hardware development. ---
58  2013 Improved metered dose inhaler technique when a coordination cap is used. MDI, PIF, SD, TI
59  2013 The use of metered-dose inhalers in hospital environments. COPD
60  2013 Use of metered-dose inhaler electronic monitoring in a real-world asthma randomized controlled trial. ---
61  2012 Effect of the moisture content in aerosol on the spray performance of Stmerin D hydrofluoroalkane preparations (2). FPD, RH
62  2012 Prospective, open-label assessment of albuterol sulfate hydrofluoroalkane metered-dose inhaler with new integrated dose counter. HFA
63  2012 Survey of aerosol delivery techniques to spontaneously breathing tracheostomized children. ---
64  2012 The president speaks: prevention is best: lessons from protecting the ozone layer. CFC, HFC
65  2012 Use of inhaler devices and asthma control in severe asthma patients at a referral center in the city of Salvador, Brazil. ---
66  2011 Assessment of metered dose inhaler technique in patients with chronic lung disease at government hospitals of Rawalpindi. ---
67  2011 Telephonic monitoring and optimization of inhaler technique. ---
68  2010 Formulation strategy and use of excipients in pulmonary drug delivery. DPIs
69  2010 Pharmaceutical care for patients with persistent asthma: assessment of treatment compliance and use of inhaled medications. DPIs
70  2010 Repeat dosing of albuterol via metered-dose inhaler in infants with acute obstructive airway disease: a randomized controlled safety trial. HFA
71  2010 Use of ozone-depleting substances; removal of essential-use designation (flunisolide, etc.). Final rule. EPA, FDA, ODSs
72  2009 A two one-sided parametric tolerance interval test for control of delivered dose uniformity. Part 1--characterization of FDA proposed test. DDU, DPIs, PTI, TOST
73  2009 Albuterol metered dose inhaler performance under hyperbaric pressures. ---
74  2009 Bronchodilatation effects of a small volume spacer used with a metered-dose inhaler. ---
75  2009 Comparison of inhaled corticosteroids: an update. ---
76  2009 Multicentre evaluation of an emergency department asthma care pathway for adults. ACP, ED, PEFR
77  2009 New HPLC assay for urinary salbutamol concentrations in samples collected post-inhalation. HPLC, SPE, USAL
78  2009 Not all asthma inhalers are the same: factors to consider when prescribing an inhaler. DPIs
79  2009 Once-daily ciclesonide via metered-dose inhaler: Similar efficacy and safety with or without a spacer. CIC160, ICS, ITT, PP
80  2009 Switching from CFC to HFA Inhalers: What NPs and Their Patients Need to Know. CFC, HFA
81  2008 Accounting for the effects of moderately increased pressure on the energetics of melting and solubility in metered dose inhalers. ---
82  2008 Cost effectiveness of asthma treatment with a breath-actuated inhaler: how has the story changed? BAIs
83  2008 Evaluation of impaction force of nasal sprays and metered-dose inhalers using the Texture Analyser. ANDAs
84  2008 Handling of inhaler devices in actual pulmonary practice: metered-dose inhaler versus dry powder inhalers. DPIs
85  2008 Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals. FP, FPF, HFA, SX
86  2008 Measurements of electrodynamic effects on the deposition of MDI and DPI aerosols in a replica cast of human oral-pharyngeal-laryngeal airways. COPD, DPIs, ESPART, OPL
87  2008 Minimizing variability of cascade impaction measurements in inhalers and nebulizers. APSD, CI, DPIs, QbD
88  2008 Patient medication knowledge and adherence to asthma pharmacotherapy: a pilot study in rural Australia. ---
89  2008 Switching to CFC-free beclometasone for asthma. CFC, HFAs
90  2007 A comparative study of patients' preferences and sensory perceptions of three forms of inhalers among Thai asthma and COPD patients. DPI
91  2007 A modified prescription-event monitoring study to assess the introduction of Seretide Evohaler in England: an example of studying risk monitoring in pharmacovigilance. CFC, PEM, RR
92  2007 Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? DPIs, NT, PIF
93  2007 Chlorofluorocarbon-free inhalation devices in asthma: are there clinical implications? BDP, CFC, HFA
94  2007 Devices for aerosol delivery to treat sinusitis. ---
95  2007 New analytical techniques to facilitate preformulation screening in propellant systems. ---
96  2007 The potential of a 2Tone Trainer to help patients use their metered-dose inhalers. AQLQ, CI, GT, PIF, VT
97  2006 Assessment of inhalation technique in primary care asthmatic patients using metered-dose inhalers with or without a spacer. MDI, PHCs
98  2006 Economics of "essential use exemptions" for metered-dose inhalers under the Montreal Protocol. CFCs, COPD, EUEs
99  2006 Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction. COPD
100  2006 Life-threatening asthma and anaphylaxis in schools: a treatment model for school-based programs. AAPs, OPSs